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Abstract: Despite considerable interest in improving clinical and neurobiological characterisation of
frontotemporal dementia and in defining the role of brain network disintegration in its pathogene-
sis, information about white matter pathway alterations in frontotemporal dementia remains lim-
ited. Here we investigated white matter tract damage using an unbiased, template-based diffusion
tensor imaging (DTI) protocol in a cohort of 27 patients with the behavioral variant of frontotempo-
ral dementia (bvFTD) representing both major genetic and sporadic forms, in relation both to
healthy individuals and to patients with Alzheimer’s disease. Widespread white matter tract
pathology was identified in the bvFTD group compared with both healthy controls and Alzheimer’s
disease group, with prominent involvement of uncinate fasciculus, cingulum bundle and corpus
callosum. Relatively discrete and distinctive white matter profiles were associated with genetic sub-
groups of bvFTD associated with MAPT and C9ORF72 mutations. Comparing diffusivity metrics,
optimal overall separation of the bvFTD group from the healthy control group was signalled using
radial diffusivity, whereas optimal overall separation of the bvFTD group from the Alzheimer’s dis-
ease group was signalled using fractional anisotropy. Comparing white matter changes with
regional grey matter atrophy (delineated using voxel based morphometry) in the bvFTD cohort
revealed co-localisation between modalities particularly in the anterior temporal lobe, however
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white matter changes extended widely beyond the zones of grey matter atrophy. Our findings demon-
strate a distributed signature of white matter alterations that is likely to be core to the pathophysiology
of bvFTD and further suggest that this signature is modulated by underlying molecular pathologies.
Hum Brain Mapp 35:4163–4179, 2014. VC 2014 TheAuthors. Human Brain Mapping Published byWiley Periodicals, Inc.
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INTRODUCTION
The behavioral variant of frontotemporal dementia
(bvFTD) is a major neurodegenerative syndrome of
younger life [Ratnavalli et al., 2002]. It is the most common
of the canonical syndromes of frontotemporal lobar degen-
eration. The syndrome is led by progressive decline in per-
sonality and inter-personal skills with emergence of a
range of behavioral abnormalities including obsessionality,
loss of empathy and apathy [Rascovsky et al., 2011]. Most
cases are associated with pathology in the frontotemporal
lobar degeneration (FTLD) spectrum, however pathological
substrates are heterogeneous [Rohrer et al., 2011; Seelaar
et al., 2011]. The neuroimaging features of bvFTD are also
variable: typically, there is cortical atrophy involving the
frontal and temporal lobes, often asymmetric between the
cerebral hemispheres [Rohrer et al., 2011; Whitwell and
Josephs, 2011]. Despite much recent interest, prediction of
tissue pathology from clinical and neuroanatomical fea-
tures in bvFTD remains problematic [Seelaar et al., 2011],
yet this is likely to be crucial both for understanding the
neurobiology of bvFTD and for the evaluation and moni-
toring of future disease-modifying therapies. The concept
of network-led neurodegeneration offers a potentially uni-
fying neurobiological basis for the diverse spectrum of
clinical and neuroimaging phenotypes produced by patho-
genic proteins [Raj et al., 2012; Zhou et al., 2012]. Network
disintegration in bvFTD has been demonstrated using
functional MRI and distributed grey matter changes com-
patible with network breakdown have been established
[Rohrer et al., 2010; Seeley et al., 2009; Whitwell and
Josephs, 2011; Whitwell et al., 2005, 2012]. In particular, an
anteriorly directed “salience” processing network includ-
ing anterior cingulate, insula and prefrontal cortices has
been implicated in the pathogenesis of bvFTD [Seeley
et al., 2009]. However, there remains a paucity of informa-
tion on the changes occurring within white matter tracts,
which provide structural connectivity underpinning large-
scale brain networks by binding together cortical and sub-
cortical regions. Furthermore, besides common syndromic
profiles of network damage there may be distinct neuroa-
natomical subgroups within the bvFTD spectrum with rel-
ative specificity for particular molecular pathologies
[Warren et al., 2012]. Identifying profiles of white matter
pathway damage along molecular lines in bvFTD would
both validate the concept of network-led degeneration and
potentially allow additional (or more robust) stratification
of neuroanatomical subgroups within the bvFTD spectrum
that might map more closely onto pathological and genetic
substrates.
The comparatively recent advent of diffusion tensor
imaging (DTI) allows such white matter tract profiles to be
delineated. A particular potential strength of DTI is the
generation of multiple quantitative metrics of white matter
alteration (diffusivity) during a single acquisition. The
neurobiological significance of these metrics remains rela-
tively little explored: whilst fractional anisotropy (FA) has
been the most widely cited metric, more recent studies
have suggested that use of the individual parameters of
diffusion may be more appropriate in neurodegeneration
[Acosta-Cabronero et al., 2010; Mahoney et al., 2013]. Fur-
ther it has been suggested that particular DTI metrics such
as axial diffusivity (AX) radial diffusivity (RD) and trace
diffusivity (TR) may have specificity for particular patholo-
gies [Nair et al., 2005; Song et al., 2002] although this
remains controversial [Jones et al., 2013; Wheeler-
Kingshott and Cercignani, 2009]. Previous studies (see
Table I) of white matter tract damage in bvFTD have been
relatively small and there is limited information about
tract alterations associated with particular bvFTD patholo-
gies and how these compare with other common neurode-
generative disorders such as Alzheimer’s disease (AD).
Often only FA has been assessed, potentially anatomically
biased ‘seed-based’ approaches have been used or techni-
cal factors such as normalisation-associated distortion have
not been fully addressed [Agosta et al., 2011; Whitwell
et al., 2010; Zhang et al., 2009, 2013]. More fundamentally,
it remains unclear how white matter alterations relate to
the more familiar profiles of grey matter atrophy in
bvFTD.
In this study, we set out to define in detail profiles of
white matter tract damage using DTI in a comprehen-
sively characterized cohort of patients with bvFTD repre-
senting major genetic as well as sporadic forms, in
relation both to healthy control individuals and to
patients with AD. We hypothesized that separable pro-
files of white matter pathology would be identified within
this broad bvFTD spectrum and in comparison to AD.
Subsidiary aims of our study were to compare the pro-
files of different diffusivity metrics in bvFTD, using ana-
tomically unbiased tract-based and customised dementia
template-based techniques; and to compare white matter
alterations in relation to the distribution of grey matter
atrophy.
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METHODS
Participants
Twenty-seven consecutive patients who fulfilled a diag-
nosis of probable or definite bvFTD based on current con-
sensus criteria [Rascovsky et al., 2011] were recruited
from the Specialist Cognitive Disorders Clinic at the
National Hospital for Neurology and Neurosurgery. The
bvFTD cohort included 14 patients with either neuropa-
thologic confirmation or pathogenic mutations in the
MAPT or C9ORF72 genes, three subjects with C9ORF72
have previously had their neuroimaging findings reported
elsewhere [Mahoney et al., 2012a]. Twenty healthy older
volunteers and 25 patients with a diagnosis of probable
AD [Dubois et al., 2007] also participated. Participants
underwent a structured clinical and neuropsychological
assessment (see Supporting Information for detailed infor-
mation on tests used) and structural magnetic resonance
imaging (MRI) to exclude significant vascular disease or
other focal cerebral lesions. Demographic and neuropsy-
chological data were analyzed in STATA12VR (Statacorp)
using Student’s t test and Wilcoxon rank-sum tests of sta-
tistical significance.
Ethical approval for the study was obtained from the
local institutional ethics committee and all participants
gave written informed consent to participate in accordance
with the Declaration of Helsinki.
Genetic Analysis of Subjects
All 27 patients were asked to contribute a DNA sample
for genetic analysis; one patient declined and one patient
later withdrew consent for testing; both of these patients
had no family history and were therefore considered to
have sporadic disease. The remaining 25 patients under-
went genetic sequencing of MAPT, PGRN, or C9ORF72
using either direct Sanger sequencing or with next genera-
tion sequencing technology using Life Technology’s Ion
Torrent Personal Genome Machine sequencing; which
additionally screened for mutations within fused-in-
sarcoma, valosin-containing protein, charged multivesicu-
lar body protein 2B, prion protein, TAR DNA-binding pro-
tein 43, presenilin 1 and 2, amyloid precursor protein and
colony stimulating factor 1 receptor genes.
Acquisition of Brain Images
Brain MRI data were acquired for all participants on a
Siemens Trio 3T MRI scanner using a 32-channel phased
array head-coil (Siemens, Erlangen, Germany). Two 64-
direction DTI sequences were acquired with a single shot,
spin-echo echo planar imaging sequence (55 contiguous
axial 2.5 mm slices with 240 mm field of view and 96 3 96
matrix, yielding 2.5 mm isotropic voxels; repetition time:
6,800 ms; echo time: 91 ms; b value: 1,000 s/mm2),
TABLE I. Comparison of fractional anisotropy changes in studies of frontotemporal dementia using diffusion tensor
imaging
Study Participants
MRI
acquisition Software
Tract
selection
Statistical
method Tracts
Matsuo et al.,
2008
12 bvFTD,
17 Controls
1.5 Tesla,
15 directions
PRIDE ROI Mann-Whitney U AF, UF, ILF, CC
Zhang et al.,
2009
18 bvFTD;
18 AD;
19 Controls
4 Tesla;
6 directions
Volume-
one/dTV
Whole
brain, ROI
MANOVA/
multiple
regression
Anterior CC, UF,
anterior/descending/
left posterior CB
Whitwell et al.,
2010
16 bvFTD;
19 Controls
3 Tesla;
21 directions
DTI Studio ROI ANCOVA Anterior CB, UF, SLF,
right anterior ILF,
right CST
Agosta et al.,
2011
13 bvFTD;
25 Controls
3 Tesla;
32 directions
FDT/TBSS Whole
brain, ROI
Permutation
test (n 5 5,000)
CB, Fornix, CC, SLF,
UF, ILF, Parahippocamal
tract
Lillo et al.,
2012
15 bvFTD;
18 Controls
3 Tesla;
32 directions
FDT/TBSS Whole brain Permutation
test (n 5 5,000)
Anterior CC, anterior ILF, CST
Zhang et al.,
2013
13 bvFTD;
19 Controls
4 Tesla;
6 directions
SPM8 Whole
brain, ROI
Two-sample t-test UF, anterior CC
Present study 27 bvFTD;
25 AD;
20 Controls
3 Tesla;
64 directions
Camino/TBSS Whole
brain, ROI
Permutation
test (n 5 10,000)
UF, CB, CC, SLF, ILF,
ATR, CST
Tracts listed are bilateral unless otherwise stated. A statistical threshold of P <0.05 was used for citing tracts with significant change
from individual papers. AD, Alzheimer’s disease; ANCOVA, analysis of covariance; AF, Arcuate Fasciculus; ATR, anterior thalamic
radiation; CB, cingulum bundle; CC, corpus callosum; Controls, older healthy control participants; CST, corticospinal tract; DTI, diffu-
sion tensor imaging; FDT, FMRIB diffusion toolbox; bvFTD, frontotemporal dementia; ILF, inferior longitudinal fasciculus; MANOVA,
Multivariate analysis of variance; PRIDE, Philips Research Integrated Device Environment; ROI, region of interest; SLF, superior longitu-
dinal fasciculus; SPM8, Statistical Parametric Mapping version 8; TBSS, tract based spatial statistics; UF, uncinate fasciculus.
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augmented with parallel imaging acceleration to reduce
susceptibility artifacts. Nine images without diffusion
weighting were also acquired (b 5 0 s/mm2). Other
sequences acquired were a sagittal three-dimensional mag-
netization-prepared rapid gradient echo T1-weighted volu-
metric MRI (echo time/repetition time/inversion time 5
2.9/2,200/900 ms, dimensions of 256 3 256 3 208, voxel
size of 1.1 3 1.1 3 1.1 mm) and a coronal fluid-attenuated
inversion recovery MRI. For all participants, volumetric
MRI, DTI, and fluid-attenuated inversion recovery sequen-
ces were assessed visually in all planes to ensure adequate
coverage and to exclude artifacts, unexpected pathology,
or significant motion.
Preprocessing of Diffusion Tensor Data
Raw diffusion weighted images were affine-aligned to
the first corresponding b0 image using a linear image
registration tool (FLIRT v5.5) within the FMRIB Software
Library (FSL v4.1.5) [Cook et al., 2006; Smith et al., 2006].
DTI volumes were then combined for tensor fitting using
Camino (http://cmic.cs.ucl.ac.uk/camino/), and FA and
other DTI metrics at each voxel then derived from the ten-
sor eigenvalues (k1, k2, and k3; where AX 5 k1, RD 5 (k2
1 k3)/2, trace (TR) 5 (k1 1 k2 1 k3)) and fractional ani-
sotropy (FA)
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. To reduce the effect of
atrophy-related distortion in registering and projecting to a
common white matter skeleton and improve image align-
ment in creating the group-wise skeleton a group-wise atlas
was used within the TBSS pipeline [Keihaninejad et al.,
2012]. This methodology aims to improve the quality of
image registration in neurodegenerative conditions by mini-
mizing the effects of stretch and distortion seen when
attempting to warp a brain affected by significant neurode-
generation onto the standard FMRIB58 image (based on 58
scans of healthy individuals aged 20–50 years). It also
reduces image distortion in regions affected by severe atro-
phy and provides greater detail on distal parts of white mat-
ter tracts compared with the standard TBSS pipeline
(compare images generated using this versus standard
approaches in Supporting Information Fig. 1).
Analysis of Diffusion Tensor Data
To assess disease effects on white matter structures a
general linear model was created with disease group
membership as the factor of interest and age, gender, and
disease duration (as a surrogate of disease severity and
stage) included as nuisance covariates. Each metric (AX/
RD/TR/FA) was analyzed with the above model, and
additionally with a model that included the overall mean
of the metric under study as an additional covariate. The
latter model reveals areas that are specifically affected
after adjusting for widespread global differences, analo-
gous to controlling for total grey matter volume in
voxel-based morphometry [Mechelli et al., 2005]. Models
were contrasted with both healthy and disease control
groups. A genetic subgroup analysis was performed com-
paring MAPT and C9ORF72 mutation groups with healthy
individuals, the AD disease group and with each other
using the same model design. Statistical analysis was
implemented using the permutation-based (nonparametric)
“randomise” tool within FSL with 10,000 permutations for
each test. A significance threshold (P < 0.05) was applied
after correction for multiple comparisons using family-
wise error (FWE) correction with threshold-free cluster
enhancement (TFCE) [Smith and Nichols, 2009]. Significant
results were projected onto a study-specific average brain
registered to standard (Montreal Neurological Institute;
MNI) space. To provide accurate anatomic localisation a
series of tract-specific masks were applied to the signifi-
cant whole brain results. Tracts corresponding to major
white matter structures were selected from a probabilistic
atlas [Mori et al., 2004], and to adjust for the anatomical
variability of the tract thresholded at a likelihood of over-
lap across individuals of 20%, this moderately stringent
threshold is also likely to reduce contamination within
regions-of-interest by reducing partial volume effects and
erroneous inclusion of grey matter. This figure was
deemed acceptable as it allowed for maximal tract cover-
age whilst minimising the possibility of overlap between
neighbouring tracts (i.e. inferior longitudinal fasciculus
and uncinate fasciculus, see Supporting Information Fig.
2). The aim was to include the core of the tract, whilst
excluding peripheral parts of the tract with high inter-
individual variability [Hua et al., 2008]. A total of 14
binary masks were created, covering major white matter
pathways including right and left inferior longitudinal fas-
ciculus (ILF), superior longitudinal fasciculus (SLF), unci-
nate fasciculus, anterior thalamic radiation (ATR),
cingulum bundle, corticospinal tract (CST), corpus cal-
losum, and fornix. Further information on the significant
(FWE-corrected) results was extracted from within each
anatomical mask (using FSL’s “fslstats”). The proportion of
significantly affected voxels within each tract was calcu-
lated by dividing the number of significant voxels identi-
fied by the total number of voxels within each tract
limited to within the skeleton. In addition, to assess the
anatomical reliability of results obtained from the group
skeleton, result maps were de-projected and overlaid on
each individual participant’s FA image, which confirmed
good anatomical alignment of the results with white mat-
ter tracts.
Sensitivity and Specificity of Diffusion Metrics in
Predicting Group Membership
To determine the sensitivity and specificity of different
diffusivity metrics in classifying individual participants
into separate groups (bvFTD/healthy individual/AD)
receiver operating characteristic (ROC) curves were
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constructed and areas-under-curve (AUC) were calculated.
Two approaches were used for the classification, assessing
respectively the mean of each individual metric (FA, AX,
RD, TR) across the whole white matter skeleton and the
mean values within individual tracts identified as promi-
nently involved in the initial DTI analysis. Mean values
were extracted using the “fslmeants” command. ROC
curves and AUC values were calculated for both global
and individual tract diffusivity data.
Grey Matter Analysis
In order to compare white with grey matter changes in
the bvFTD cohort, profiles of grey matter atrophy were
first derived using voxel-based morphometry (VBM) with
the New Segment [Weiskopf et al., 2011] and DARTEL
[Ashburner, 2007] toolboxes of SPM8 (www.fil.ion.ucl.ac.
uk/spm) under Matlab 7.14 (www.mathworks.com). Seg-
mentation, normalization, and modulation were performed
using default parameter settings. Smoothing of grey matter
images used a 6 mm kernel size. Final DARTEL transfor-
mations were combined with affine transformations to
MNI space. To maintain consistency with the white matter
analysis, grey matter was assessed using the same statisti-
cal methodology. Nonparametric permutation testing (n 5
10,000) was used to examine differences in regional grey
matter volume between groups and included age, gender,
total intracranial volume and disease duration as nuisance
covariates. Maps of grey matter atrophy were overlaid
onto an MNI152 standard brain after FWE correction (P <
0.05) with TFCE. To provide information on the anatomical
relationship of the grey and white matter changes, an inter-
section map of all four DTI metrics (derived by combining
the individual mean-adjusted bvFTD versus healthy control
result maps, thresholded using FWE-correction P < 0.05)
were overlaid on the map of grey matter atrophy.
RESULTS
Participant Clinical Characteristics
Of the 27 patients with bvFTD identified (mean age
62.5 6 9.0 years; male 5 20) 14 met criteria for a diagnosis
of definite bvFTD and 13 met criteria for a diagnosis of
probable bvFTD [Rascovsky et al., 2011]. Of those with
definite bvFTD nine had mutations in the MAPT gene
(five harbored the intron 10 1 16 mutation, two harbored
the exon 13 R406W mutation, one harbored the exon 10
P301S mutation, and one harbored a novel mutation in
exon 12 resulting in a single amino acid substitution at
codon 351 (Q351R)), four had mutations in C9ORF72 and
one patient who subsequently died was found to have
Pick’s disease pathology at postmortem. In addition to
meeting diagnostic criteria for bvFTD, two patients had
symptoms compatible with Progressive Supranucelar Palsy
(both having sporadic bvFTD), two had symptoms
compatible with motor neuron disease (one having a
C9ORF72 mutation, one being sporadic) and one had
symptoms compatible with corticobasal syndrome (being
sporadic). All AD patients had a typical memory-led pre-
sentation. Demographic, clinical and neuropsychological
data for all participant groups are summarised in Table II.
The healthy control and AD groups were comparable in
age and gender characteristics (healthy control group
mean age 64.5 6 4.5 years, male 5 13/20; AD group mean
age 63.1 65.2 years; male 5 17/25). CSF data was avail-
able on 13 of 27 bvFTD patients, all had profiles compati-
ble with non-Alzheimer’s pathology (normal Abeta1–42
and normal or elevated total tau), although one subject
had low Abeta1–42 and low/normal tau which was felt to
be consistent with a handling error. CSF data was avail-
able on 11 of 25 AD patients, all had profiles compatible
with AD pathology (low Abeta1–42, elevated total tau). A
detailed general neuropsychological assessment was com-
pleted in 69 of 72 participants (one patient with bvFTD
and two with AD were unable to comply with testing).
Profiles of performance in the patient groups were in
keeping with clinical syndromes: both disease groups
showed widespread deficits compared with the healthy
control group, however, the AD group performed inferi-
orly to the bvFTD group on tests of arithmetic and general
executive capacity while the bvFTD group performed infe-
riorly to the AD group on semantic processing.
White Matter Tract Alterations in
Frontotemporal Dementia
Widespread white matter tract pathology was identified
in the bvFTD group compared with both the healthy con-
trol group and the AD group (Figs. 1–4). Data quantifying
the extent and significance of alteration within the most
affected white matter tracts compared with healthy con-
trols and AD are listed in Tables III and IV, respectively;
complete data on each metric and region of interest are
provided in Supporting Information (Supporting Informa-
tion Tables I to III). Here we first report data without cor-
rection for global DTI metric effects, in order to present a
complete picture of white matter tract alterations; we then
report data after global DTI metric correction, identifying
white matter pathology with greater anatomical specificity.
Compared with the healthy control group (Table III and
Supporting Information Table I), the bvFTD group showed
most significant and consistent white matter pathology
across diffusivity metrics (increased AX/RD/TR, decreased
FA in bvFTD) in bilateral uncinate fasciculus, cingulum
bundle, corpus callosum, and somewhat less prominently in
SLF, ILF, ATR, and fornix. Comparing DTI metrics, the
most extensive white matter damage (% of significant voxels
within a white matter tract) was detected in right uncinate
fasciculus using TR and RD. Compared with the AD group
(Table IV and Supporting Information Table II), the bvFTD
group again showed most significant and consistent white
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matter pathology across metrics (increased RD/TR,
decreased FA in bvFTD) in bilateral uncinate fasciculus,
cingulum bundle, and corpus callosum, and somewhat less
prominently in SLF, ILF, ATR, and fornix; comparing DTI
metrics, comparably extensive white matter damage was
detected in right uncinate fasciculus using RD, FA or TR.
The reverse contrasts (increased AX/TR/RD, decreased FA
in the healthy control and AD groups) did not identify any
areas of significant white matter alteration.
After correction for the effects of global mean diffusivity
values, more focal profiles of white matter alteration
emerged. Compared with the healthy control group (Sup-
porting Information Table I see also DTI intersection map
in Fig. 6), the bvFTD group showed most significant and
consistent white matter tract pathology across metrics
(increased AX/TR/RD, decreased FA in bvFTD) in right
uncinate fasciculus; comparing DTI metrics, the most
extensive white matter damage was detected in right
uncinate fasciculus using AX. Compared with the AD
group (Supporting Information Table II), the bvFTD group
showed most significant and consistent white
matter pathology across metrics (increased AX/TR/RD in
bvFTD) in bilateral uncinate fasciculus; comparing DTI
metrics, the most extensive white matter damage was
detected in right uncinate fasciculus using RD followed
by TR. Conversely, compared with the bvFTD group,
the AD group showed greater white matter damage
(increased TR/RD in AD) in posterior left hemispheric
white matter tracts (SLF and ILF); comparing DTI metrics,
the most extensive white matter alterations in the AD
group compared with bvFTD group were detected in left
ILF using TR.
TABLE II. Summary of demographic, clinical and neuropsychological data for all groups
Characteristic
bvFTD;
n 5 27
(M20:F7)
AD; n 5 25
(M17:F8)
Controls;
n 5 20
(M13:F7) Group comparisons: P value
Mean SD Mean SD Mean SD
bvFTD,
v control
bvFTD,
v, AD
AD, v,
control
Clinical
Age all subjects (years) 62.5 9.0 63.1 5.2 64.5 4.5 ns ns ns
Sporadic 64.9 8.6
MAPT 58.2 9.0
C9ORF72 64.1 8.7
MMSE (/30) 24.2 5.9 20.0 5.1 29.6 0.6 <0.001 <0.01 <0.001
Duration all subjects (years) 6.5 4.9 5.7 3.4 — — — ns —
Sporadic 6.0 4.4
MAPT 6.0 5.4
C9ORF72 9.4 5.9
CSF (bvFTD n 5 13, AD n 5 11)
Total Tau (pg/mL) 287 141 833 229
Abeta1-42 (pg/mL) 676 281 240 73
Neuropsychologicala
VIQ 81.2 23.4 90.6 19.4 123.3 9.6 <0.001 ns <0.001
PIQ 88.6 19.1 83.3 18.7 118.1 10.9 <0.001 ns <0.001
Recognition memory: words (/50) 33.3 10.1 29.4 7.8 48.1 2.3 <0.001 0.08 <0.001
Recognition memory : faces (/50) 32.8 6.8 33.7 6.3 41.9 4.7 <0.001 ns <0.001
Digit span: forward (/12) 7.1 2.2 6.3 2.2 9.1 1.4 0.002 ns <0.001
Digit span: reverse (/12) 5.5 2.7 4.3 3.0 6.8 1.8 ns 0.09 0.002
BPVS (/150) 116.5 38.0 132.5 24.3 147.9 1.5 <0.001 0.02 <0.001
Graded naming test (/30) 10.8 9.1 13.9 8.4 26.0 2.1 <0.001 ns <0.001
Graded arithmetic test (/24) 12.1 6.9 5.3 4.0 14.1 5.4 0.4 <0.001 <0.001
VOSP (/20) 15.7 3.2 15.0 3.3 18.8 1.1 <0.001 ns <0.001
DKEFS: color naming (max 90 secs) 45.6 22.9 55.0 18.7 31.2 4.7 0.03 0.03 <0.001
DKEFS: word naming (max 90 secs) 35.1 23.6 36.6 15.3 21.5 3.4 0.02 0.1 <0.001
DKEFS: ink naming (max 180 secs) 100.4 48.4 141.0 44.0 56.8 11.5 <0.001 0.003 <0.001
Group comparisons significant at P < 0.05 are shown in bold.
aNeuropsychological data not collected for one patient with bvFTD and two patients with AD.
AD, Alzheimer’s disease; BPVS, British Picture Vocabulary Scale; DKEFS, Delis-Kaplan Executive Function System; F, female; bvFTD,
frontotemporal dementia; M, male; MMSE, Mini-Mental State Examination score; ns, non-significant. PIQ, performance IQ; SD, standard
deviation (values shown in italics); VIQ, verbal IQ; VOSP, Visual Object and Space Perception battery. See Supporting Information for
details of neuropsychological tests used.
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Figure 1.
Unadjusted white matter tract data: Patterns of white matter
alteration in the behavioral variant frontotemporal dementia
(bvFTD) group compared with the healthy control group (above,
rendered on representative coronal MRI sections from a cus-
tomised group template and displayed in standard space; the
right hemisphere (R) is shown on the left) and the Alzheimer’s
disease (AD) group (below, rendered on representative coronal
sections), uncorrected for global diffusivity effects. Results for
particular diffusivity metrics (AX, axial diffusivity; FA, fractional
anisotropy; RD, radial diffusivity; TR, trace diffusivity) are shown
separately. The colour scale indexes P values after family-wise
error correction for multiple comparisons over the whole brain.
[Color figure can be viewed in the online issue, which is avail-
able at wileyonlinelibrary.com.]
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Figure 2.
Adjusted white matter tract data: Patterns of white matter alteration
in the behavioral variant frontotemporal dementia (bvFTD) group
compared with the healthy control group (rendered on representa-
tive coronal and axial MRI sections from a customised group tem-
plate and displayed in standard space; the right hemisphere (R) is
shown on the left), after correction for mean global diffusivity value.
Results for particular diffusivity metrics (AX, axial diffusivity; FA, frac-
tional anisotropy; RD, radial diffusivity; TR, trace diffusivity) are
shown separately. The colour scale indexes P values after family-wise
error correction for multiple comparisons over the whole brain.
[Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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White Matter Tract Alterations in Genetic
Subgroups
Analyses based on small numbers of cases revealed white
matter tract signatures associated with particular genetic
subgroups of bvFTD (mutations in MAPT vs. C9ORF72)
after global mean value correction (Fig. 3 and Supporting
Information Table III). Compared to the healthy control
group, the MAPT mutation subgroup showed consistent
alterations in left uncinate fasciculus across diffusivity met-
rics, albeit highly variable in extent within the tract; the
most extensive alterations were detected with AX, which
revealed additional involvement of right uncinate fascicu-
lus, corpus callosum, fornix and bilateral ILF and SLF. Com-
pared with the AD group, the MAPT mutation subgroup
showed altered RD and TR in CST, ATR, ILF and uncinate
fasciculus; again, these alterations varied widely in extent
between diffusivity metrics. Alterations detected in the
smaller C9ORF72 mutation subgroup were less extensive:
compared with the healthy control group, the C9ORF72
mutation cases showed increased AX in corpus callosum
Figure 3.
Adjusted white matter tract data: Patterns of white matter alter-
ation in the MAPT and C9ORF72 mutation groups compared with
the healthy control group and the Alzheimer’s disease (AD)
group (rendered on representative coronal, axial and sagittal
MRI sections from a customised group template and displayed in
standard space; the right hemisphere (R) is shown on the left;
sagittal sections display left hemisphere (L)), after correction for
mean global diffusivity value. Results for AX (axial diffusivity),
RD (radial diffusivity) and FA (fractional anisotrophy) are thresh-
olded at P < 0.05 FWE correction. The colour scale indexes
P values after family-wise error correction for multiple compari-
sons over the whole brain. [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
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and cingulum bundle. On direct comparison of MAPT with
C9ORF72 those with MAPT showed alterations in white
matter within the left anterior temporal pole, as measured
by reduced FA. Contrasts ofMAPT and C9ORF72mutations
subgroups with sporadic bvFTD were examined but did not
reach statistical significance.
Figure 4.
Adjusted white matter tract data: Patterns of white matter
alteration in the behavioral variant frontotemporal dementia
(bvFTD) group compared with the Alzheimer’s disease (AD)
group (rendered on representative coronal and axial MRI sec-
tions from a customised group template and displayed in stand-
ard space; the right hemisphere (R) is shown on the left), after
correction for mean global diffusivity value. Results for particu-
lar diffusivity metrics (AX, axial diffusivity; FA, fractional
anisotropy; RD, radial diffusivity; TR, trace diffusivity) are shown
separately. Panels above show white matter damage greater in
bvFTD than AD, panels below show white matter damage
greater in AD than bvFTD. The colour scale indexes P values
after family-wise error correction for multiple comparisons over
the whole brain. [Color figure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
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Comparison of Diffusivity Metrics
Comparing AUC data between DTI metrics (Fig. 5),
whole brain mean RD had the greatest sensitivity (82%)
and specificity (80%) for distinguishing the bvFTD group
from the healthy control group; TR performed compara-
bly, and AX and FA somewhat less favourably. Compar-
ing specific white matter tracts of interest using mean RD
(Fig. 5), corpus callosum, left uncinate fasciculus, and left
cingulum bundle showed high sensitivity (93%, 82%, and
74%, respectively) and specificity (75%, 75%, and 70%,
respectively) for distinguishing the bvFTD group from the
healthy control group. Whole brain mean FA had the
greatest sensitivity (78%) and specificity (68%) for distin-
guishing the bvFTD group from the AD group (Fig. 5);
RD, TR, and AX performed somewhat less favourably.
Comparing specific white matter tracts of interest using
mean FA (Fig. 5), left uncinate fasciculus showed the
greatest sensitivity (77%) and specificity (68%); left cingu-
lum bundle and corpus callosum showed slightly lower
sensitivity (63% and 56%, respectively) but greater specific-
ity (80% for both).
White Matter Tract Alterations Compared With
Grey Matter Atrophy
In the VBM analysis, compared with the healthy control
group the bvFTD group showed, as anticipated, areas of
significantly (P < 0.05 after whole-brain FWE correction
for multiple voxel-wise comparisons with TFCE) reduced
grey matter predominantly distributed in frontal and tem-
poral cortices in both cerebral hemispheres (Fig. 6).
Regions of grey matter atrophy included bilateral orbito-
frontal cortex, superior and inferior frontal gyri, insular
cortex, left cingulate gyrus, bilateral amygdala, right mid-
dle, and inferior temporal gyri. Compared with the
healthy control group the AD group also showed the
anticipated profile of grey matter atrophy, predominantly
involving medial temporal lobe and temporo-parietal
regions (Supporting Information Fig. 3). The intersection
map of DTI metrics with grey matter atrophy in the
bvFTD group (Fig. 6) showed that white matter damage
generally occurred in close anatomical proximity to areas
of grey matter atrophy, particularly in right anterior tem-
poral lobe and for uncinate fasciculus. However, compared
with the distribution of grey matter atrophy, white matter
damage across diffusivity metrics was spatially more
extensive, particularly dorsally and posteriorly within the
hemispheres. White matter changes (assessed using AX or
FA) also extended beyond apparent zones of grey matter
atrophy in the AD group (Supporting Information Fig. 3).
DISCUSSION
Here we have employed quantitative, image
registration-based DTI methods to demonstrate profiles of
white matter tract damage in a large cohort of patients
with bvFTD, representing the major genetic and sporadic
disease subtypes. Considering the bvFTD cohort firstly as
a whole, white matter changes in comparison to healthy
older individuals were extensive, distributed in both cere-
bral hemispheres with particularly prominent involvement
of the uncinate fasciculus, cingulum bundle and corpus
callosum. This white matter profile was identified after
taking disease severity into account; moreover, a similar
emphasis of white matter tract alterations was identified
when the bvFTD group was compared with the AD group,
suggesting that involvement of these tracts may be a rela-
tively specific index of pathologies in the bvFTD spectrum.
The findings were further consolidated by adjusting for
the effects of global mean diffusivity: after global adjust-
ment, involvement of uncinate fasciculus was a prominent
and consistent indicator of bvFTD pathology compared
both with healthy individuals and patients with AD.
These findings build upon and extend previous studies
of white matter tract involvement in bvFTD [Agosta et al.,
2011; Borroni et al., 2007; Matsuo et al., 2008; Whitwell
et al., 2010; Zhang et al., 2009, 2011, 2013]. Comparing tract
profiles in the present study with previous work, the
majority of studies have shown involvement of uncinate
TABLE III. Unadjusted diffusion data by metric and region of interest
bvFTD versus healthy control group
Tract
Radial diffusivity Trace diffusivity Axial diffusivity Fractional anisotropy
P value % Extent P value % Extent P value % Extent P value % Extent
Uncinate fasciculus: right 0.001 99.5 0.002 99.2 0.004 68.6 0.003 89.0
Unicinate fasciculus: left 0.002 95.3 0.002 92.5 0.002 62.2 0.003 76.5
Cingulum bundle: right 0.003 82.5 0.01 66.1 0.01 24.6 0.007 83.1
Cingulum bundle: left 0.004 74.8 0.007 61.9 0.009 16.6 0.004 78.9
Corpus callosum 0.004 65.2 0.005 66.0 0.006 45.1 0.005 63.6
Only region of interests where at least one metric had greater than 50% extent are displayed. % extent is the percentage of significant
voxels divided by total number of voxels within the masked region of the skeleton. Complete data on each metric and region of interest
are provided in Supporting Information.
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facsciculus, corpus callosum, ILF, and cingulum bundle.
However, the extent of reported white matter pathway
involvement has varied considerably between studies. The
extensive profile of white matter alterations we have dem-
onstrated here may be in part attributable to the use of a
customised white matter template as well as the
Figure 5.
Receiver operating characteristic (ROC) curves for classification of
individuals to the behavioral variant frontotemporal dementia
(bvFTD) group versus the healthy control group (left) and Alzhei-
mer’s disease (AD) group (right), based on each participant’s global
mean diffusivity data (above) and each participant’s unadjusted
mean diffusivity data within a tract region of interest (below). ROC
curves for particular diffusion tensor imaging (DTI) metrics (AX,
axial diffusivity; FA, fractional anisotropy; RD, radial diffusivity; TR,
trace diffusivity) and white matter tracts of interest (CB, cingulum
bundle; CC, corpus callosum; UF, uncinate fasciculus) are shown
separately; area-under-curve is displayed for each curve (area-
under-curve 5 1 corresponds to ideal separation of groups).
[Color figure can be viewed in the online issue, which is available
at wileyonlinelibrary.com.]
TABLE IV. Unadjusted diffusion data by metric and region of interest
bvFTD group versus Alzheimer’s disease group
Tract
Radial diffusivity Trace diffusivity Fractional anisotropy
P value % Extent P value % Extent P value % Extent
Uncinate fasciculus: right 0.002 94.4 0.006 86.2 0.004 89.3
Unicinate fasciculus: left 0.003 89.9 0.006 84.1 0.004 86.1
Cingulum bundle: left 0.003 61.8 0.008 49.2 0.004 69.0
Corpus callosum 0.007 51.0 0.008 40.4 0.006 59.8
Regions of interest where at least one metric had greater than 50% extent are displayed. % extent is the percentage of significant voxels
divided by total number of voxels within the masked region of the skeleton. Complete data on each metric and region of interest are
provided in Supporting Information.
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comparatively large cohort, which is likely to have
sampled a range of underlying pathologies within the
bvFTD spectrum, as evidenced by both the genetic data
and the presence of clinical features, in some participants,
compatible with particular underlying pathologies.
The white matter pathways delineated here are plausible
candidates to mediate brain network dysfunction and the
most prominently involved tracts have previously been
correlated with a range of cognitive deficits in the bvFTD
syndrome [Tartaglia et al., 2012]. The uncinate fasciculus
has been associated with a range of cognitive functions
and recently has been particularly implicated in the evalu-
ation of affective and other inter-personal signals [Von Der
Heide et al., 2013], and in the pathogenesis of neuro-
psychiatric symptoms [Phan et al., 2009] and risk-taking
behaviors [Linke et al., 2013]: such processes are likely to
be relevant to various canonical features of bvFTD [Ras-
covsky et al., 2011]. The uncinate fasciculus has also been
directly implicated in the modulation of inhibition in
patients with bvFTD [Hornberger et al., 2011]. The cingu-
lum bundle is intimately associated with cingulate cortex,
previously identified as a key component of the ‘salience
network’ implicated in the pathogenesis of the bvFTD syn-
drome [Kim et al., 2012; Seeley et al., 2009; Zhou et al.,
2012]. Both cingulum and corpus callosum have been
implicated in the pathogenesis of obsessive–compulsive
symptoms and executive dysfunction [Bora et al., 2011;
Linke et al., 2013]. The ATR has been linked to aspects of
attention and executive function [Andreasen et al., 1996;
Schmahmann and Pandya, 2008; Van der Werf et al., 2003]
as well as the pathogenesis of autism [Cheon et al., 2011];
while the fornix has recently been identified as a key locus
of damage in bvFTD [Hornberger et al., 2012]. The disease
specificity of other white matter associations identified
here, in particular, involvement of the long intra-
hemispheric tracts SLF and ILF, is less clear: portions of
these tracts were found to be involved more prominently
in either bvFTD or AD. This apparent paradox may reflect
Figure 6.
Maps of grey matter (GM) atrophy (light blue) and regions of
intersection of all four white matter diffusivity metrics (adjusted
for mean global diffusivity value) in the behavioral variant fronto-
temporal dementia (bvFTD) group compared with the healthy
control group. Maps are overlaid on representative coronal sec-
tions of the MNI152 template brain; the right hemisphere (R) is
shown on the left. The diffusivity tensor (DT) metric data inter-
section colour scale indexes the extent of overlap between met-
rics, i.e. dark blue indicates change in only one metric whereas
red indicates change in all four metrics; the GM colour scale
indexes P values after family-wise error correction for multiple
comparisons over the whole brain. [Color figure can be viewed
in the online issue, which is available at wileyonlinelibrary.com.]
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evolution of pathology across white matter pathways com-
mon to the distributed brain networks that are targeted in
these different neurodegenerative diseases. However, lon-
gitudinal data comparing syndromes and diseases will be
required to resolve this.
The present work further suggests that DTI can delin-
eate molecularly defined profiles of white matter pathol-
ogy within the broader bvFTD spectrum. Most striking
were alterations within the uncinate fasciculus in those
with MAPT mutations, which persisted when compared
with AD and C9ORF72 groups. These more localized
changes suggest that MAPT mutations may direct patho-
logical changes to target this ventromedial network. In
contrast those with C9ORF72 mutations tended to have
more dorsal white matter tract pathology, which targeted
the cingulum bundle and corpus callosum. These findings
are in line with evidence from previous neuroanatomical
studies of genetic subtypes of bvFTD [Mahoney et al.,
2012a, 2012b; Rohrer et al., 2011]. Notably we did not gen-
erate a significant result when MAPT was contrasted with
the sporadic bvFTD group. The absence of a result may
suggest that those with sporadic bvFTD and MAPT muta-
tions have overlapping profiles of white matter pathology,
at least in part, which is supported by the prominence of
uncinate fasciculus involvement seen when considering all
bvFTD patients collectively. This subgroup analysis does
not fully resolve neuroanatomical subtyping of molecu-
larly defined bvFTD: case numbers across subgroups were
small (precluding, for example, differentiation of individ-
ual mutations within each subgroup) while certain key
bvFTD phenotypes (in particular, bvFTD due to progranu-
lin gene mutations and sporadic forms of bvFTD associ-
ated syndromes of atypical parkinsonism or motor
neurone disease) were either underrepresented or not rep-
resented at all. The likely variability of pathologies within
the sporadic bvFTD group may also have limited the abil-
ity to detect white matter changes specific to this group.
Taking these caveats into account, the present findings
provide further evidence that the profile of regional brain
network disintegration in bvFTD may be modulated by
underlying molecular pathologies [Warren et al., 2012]
and that DTI can assist in differentiating these pathologies
in vivo.
The compatibility of different diffusivity metrics is an issue
of considerable clinical and neurobiological relevance to the
application of DTI in neurodegenerative disease. While our
findings suggest partial convergence of metrics for particular
white matter tracts, we found additional substantial diver-
gence in the white matter profiles generated using different
diffusivity metrics across both sporadic and genetic forms of
bvFTD (and indeed, also within the AD neurodegenerative
control group; compare Figures 1 to 4 and 6, and Supporting
Information Tables I to III). In principle, there is likely to be a
trade-off between higher sensitivity and higher specificity for
any candidate DTI metric, presenting a practical problem of
optimisation if particular metrics are in future to be used as
disease biomarkers. It may be that some DTI metrics have
higher inter-subject variability, in both healthy and affected
individuals, and after discounting for these affects (as we do
by adjusting for global mean diffusivity), the overall extent of
change may be less emphatic. After adjusting for global
mean diffusivity values to enhance regional anatomical speci-
ficity, we identified disproportionate involvement of unci-
nate fasciculus, suggesting it may be a candidate for
monitoring white matter changes in bvFTD across diffusivity
metrics. This was further corroborated by a formal ROC anal-
ysis assessing the separability of bvFTD from healthy indi-
viduals and patients with AD (Fig. 5). Comparing global
brain diffusivity values, RD and TR appeared most sensitive
in distinguishing bvFTD from healthy controls, in keeping
with previous work [Acosta-Cabronero et al., 2010; Agosta
et al., 2011; Mahoney et al., 2013] and suggesting these met-
rics might potentially assist in early bvFTD diagnosis. On the
other hand, FA appeared to be have a greater specificity in
distinguishing bvFTD from AD, suggesting that this metric
might be preferred as a future disease biomarker (for exam-
ple, in treatment trials targeting particular pathologies).
However, data in the genetic subgroups (see Supporting
Information Table III) suggest that the “optimal” diffusivity
metric may be further stratified within the bvFTD spectrum.
These discrepant findings between DTI metrics may have
face validity. Firstly, whilst previous studies suggest that AX
or RD may be superior to FA in detecting white matter
pathology in neurodegeneration, none have made direct
comparisons between different disease groups. Secondly, a
number of studies within other degenerative conditions have
demonstrated that FA has some specificity in distinguishing
different disease subtypes[Menke et al., 2012; Prakash et al.,
2009] This underlines the need to take the specific application
into account when evaluating candidate DTI metrics [Acosta-
Cabronero et al., 2010]. Variation among DTI metrics may in
addition potentially hold neurobiological insights: for exam-
ple, the apparent discrepancy between RD and FA in signify-
ing bvFTD (whether referenced to healthy controls or to AD)
might be driven by changes in either RD or AX as change in
either metric could affect FA.
A related key issue concerns the relationship of grey
matter atrophy to white matter damage in bvFTD. Here,
changes in white matter tracts occurred in close anatomi-
cal proximity to regions of grey matter loss but were more
spatially distributed (see Fig. 6). In line with this another
recent study has also found somewhat more widespread
white matter changes in bvFTD when compared with AD
[Zhang et al., 2011]. White matter and grey matter altera-
tions were most robustly co-localized in the right anterior
temporal lobe including the most consistently involved
white matter tract, the uncinate fasciculus. There is a need
for caution when comparing different neuroimaging
modalities, such as DTI and VBM. However, the greater
spatial extent of white matter damage might reflect distal
propagation of pathology from primarily involved regions
adjacent to regions of grey matter damage (due for
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example to pathogenic protein diffusion or withdrawal of
trophic support) [Hardy and Revesz, 2012; Warren et al.,
2012]; alternatively, however, white matter pathology
might drive grey matter loss, such that over time grey
matter atrophy spreads to become more contiguous with
white matter damage. Substantial emerging histopathologi-
cal evidence suggests that white matter pathology may be
significant in bvFTD [Ahmed et al., 2011; Hiji et al., 2008;
Neumann et al., 2007], may develop early in the disease
process [Broe et al., 2004; Martin et al., 2001] and may pro-
mote subsequent upstream cortical degeneration [Drzezga
et al., 2011; Villain et al., 2008]. Detailed longitudinal anal-
yses assessing the evolution of white matter and grey mat-
ter alterations in tandem will be required to resolve these
possibilities.
CONCLUSIONS
This work has identified profiles of white matter tract
damage in a large, representative cohort of patients with
bvFTD, demonstrating a distributed signature of white
matter alterations that is likely to be core to the patho-
physiology of the syndrome and suggesting that this sig-
nature is modulated by underlying molecular pathologies.
The study has highlighted a number of directions for fur-
ther work. Important limitations of the present study
include a sparsity of particular genetic and clinical bvFTD
subtypes and lack of histopathological correlation. Analy-
sis of altered structural connectivity may be further refined
by inclusion of robust clinical severity and neuropsycho-
logical measures within future imaging datasets. Future
studies will also likely require multi-centre collaborations
in order to recruit substantial case numbers across the
bvFTD spectrum and among disease controls, to follow
these cohorts longitudinally with white and grey matter
imaging modalities, and to correlate phenotypic with path-
ological features. Ideally this should also include histo-
morphometry to assess the relationship between
microstructural diffusion imaging changes, histopathologi-
cal changes in WM tracts and regional grey matter dam-
age. In addition to these logistical and neurobiological
challenges, this study has identified a number of technical
challenges in the application and interpretation of DTI in a
heterogeneous syndrome such as DTI. Foremost amongst
these is the richness of most DTI datasets: it remains
unclear how best to assess diffusivity metrics in relation to
one another, or whether peak change, extent of change or
some combination is the optimal index of disease. This is
true even for unitary pathologies such as AD but is com-
pounded in the face of diverse histopathological substrates
in bvFTD. The present data show extensive overlap
between metrics and tracts among diseases (bvFTD and
AD) and putative bvFTD subtypes. Ultimately, the solution
may lie in the use of multivariate or multimodal indices
and composite profiles of tract alteration that are informed
by an improved understanding of the pathobiology of
white matter diffusion and the natural history of particular
bvFTD pathologies [Avants et al., 2010; Groves et al., 2011;
Naylor et al., in press] A further challenge is the anatomi-
cal configuration of relevant white matter pathways in
bvFTD (in particular, crossing fibres) which may only be
resolved by improved imaging pipelines [Jbabdi et al.,
2010] and using methods such as tractography to assess in
greater detail the alterations within particular tracts. These
many challenges notwithstanding, our findings together
with previous work provide a clear rationale for the fur-
ther evaluation of DTI as a candidate clinical biomarker
and neurobiological probe in bvFTD.
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